The new WHO classification of brain tumours

P Kleihues, PC Burger, BW Scheithauer - Brain pathology, 1993 - Wiley Online Library
The new edition of the World Health Organization (WHO) book on 'Histological Typing of
Tumours of the Central Nervous System'reflects the progress in brain tumour classification …

Angiogenesis in malignant gliomas

KH Plate, W Risau - Glia, 1995 - Wiley Online Library
One event that accompanies glioma progression is the upregulation of angiogenesis. Low‐
grade gliomas are moderately vascularized tumors whereas high‐grade gliomas show …

[图书][B] Pathology and genetics of tumours of the nervous system.

P Kleihues, WK Cavenee - 2000 - cabidigitallibrary.org
This book on the World Health Organization (WHO) classification of tumours of the nervous
system reflects the view of a working group that convened for an editorial and consensus …

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.

R Nishikawa, XD Ji, RC Harmon… - Proceedings of the …, 1994 - National Acad Sciences
The development and neoplastic progression of human astrocytic tumors appears to result
through an accumulation of genetic alterations occurring in a relatively defined order. One …

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.

J Reifenberger, G Reifenberger, L Liu… - The American journal …, 1994 - ncbi.nlm.nih.gov
The molecular genetic alterations of oligodendroglial tumors and mixed gliomas of the
central nervous system were studied in a series of 37 cases (8 oligodendrogliomas, 13 …

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles

Y Yin, MA Tainsky, FZ Bischoff, LC Strong, GM Wahl - Cell, 1992 - cell.com
Loss of cell cycle control and acquisition of chromosomal rearrangements such as gene
amplification often occur during tumor progression, suggesting that they may be correlated …

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors

CJ Kemp, LA Donehower, A Bradley, A Balmain - Cell, 1993 - cell.com
The availability of~ 53 knockout mice generated by gene targeting has enabled us to
investigate the functional role of the~ 53 tumor suppressor gene in initiation, promotion, and …

PTEN mutations in gliomas and glioneuronal tumors

EM Duerr, B Rollbrocker, Y Hayashi, N Peters… - Oncogene, 1998 - nature.com
Cytogenetic and loss of heterozygosity studies have suggested the presence of at least one
tumor suppressor gene on chromosome 10 involved in the formation of high grade gliomas …

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

JS Smith, B Alderete, Y Minn, TJ Borell, A Perry… - Oncogene, 1999 - nature.com
Allelic alterations of chromosomes 1 and 19 are frequent events in human diffuse gliomas
and have recently proven to be strong predictors of chemotherapeutic response and …

Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.

K Watanabe, K Sato, W Biernat, O Tachibana… - Clinical cancer research …, 1997 - AACR
Mutations of the p53 tumor suppressor gene are a genetic hallmark of human astrocytic
neoplasms, but their predictive role in glioma progression is still poorly understood. We …